Advertisement
Advertisement
RGNT
Regentis Biomaterials Ltd.
2.04
USDSponsored
-0.06
-2.86%
Sep 24, 15:59 UTC -4
Closed
After-Market
2.04
0.00
+0.20%
Regentis Biomaterials Ltd. Financial Snapshot
| Market Cap | 14.36M |
| Beta | -- |
| Earnings Per Share (EPS) | -- |
| Price-to-Book (P/B) Ratio | 1.41 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -- |
| Current Ratio | -- |
| Free Cash Flow | 0.00 |